Ocular Therapeutix (OCUL) Depreciation and Depletion (2013 - 2014)
Ocular Therapeutix (OCUL) recorded quarterly Depreciation and Depletion of $139000.0 in Q3 2014, up 51.09% quarter-over-quarter from $92000.0 in Q3 2013, and up 51.09% on a YoY basis from $92000.0 in Q3 2013.
Ocular Therapeutix (OCUL) Depreciation and Depletion (2013 - 2014) Analysis & Trends
Ocular Therapeutix's Depreciation and Depletion history runs 2 years deep, the most recent figure standing at $139000.0 for Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 9.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 139,000.00 |
| Sep 30, 2014 | 139,000.00 |
| Sep 30, 2013 | 92,000.00 |
| Sep 30, 2013 | 92,000.00 |